USANA Health Sciences USNA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's financing cash flow?
- USANA Health Sciences (USNA) reported financing cash flow of -$3.64M in Q1 2026.
- How has USANA Health Sciences's financing cash flow changed year-over-year?
- USANA Health Sciences's financing cash flow increased by 74.8% year-over-year, from -$14.47M to -$3.64M.
- What is the long-term trend for USANA Health Sciences's financing cash flow?
- Over 3 years (2021 to 2024), USANA Health Sciences's financing cash flow has grown at a -62.5% compound annual growth rate (CAGR), from -$181.41M to $9.55M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.